Fresh $668 million biotech venture fund aims to quench hunger for data
A San Francisco venture capital firm backing data-intensive approaches to developing new drugs has raised a $668 million fund that it looks to turn loose on new ways to marry data and biology to bring therapies to market faster.
Foresite Capital, whose recent investments include the machine learning drug development company Insitro, recent IPO Arcus Biosciences Inc. (NYSE: RCUS) of Hayward and Pleasanton sequencing company 10X Genomics Inc., said its fourth fund will focus on companies with "technical…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Biology | Biotechnology | Health Management | Learning | Universities & Medical Training | Venture Capital